UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Supportive care in cancer, ISSN 0941-4355, 6/2013, Volume 21, Issue 6, pp. 1655 - 1663
Breakthrough nausea and emesis | Pain Medicine | Chemotherapy | Nursing | Rehabilitation Medicine | Olanzapine | Medicine & Public Health | Oncology | Metoclopramide | Nursing Management/Nursing Research | Health Care Sciences & Services | Rehabilitation | Life Sciences & Biomedicine | Science & Technology | Cyclophosphamide - administration & dosage | Isoquinolines - adverse effects | Nausea - chemically induced | Humans | Middle Aged | Antiemetics - administration & dosage | Dexamethasone - adverse effects | Male | Antineoplastic Agents - administration & dosage | Cyclophosphamide - adverse effects | Quinuclidines - administration & dosage | Cisplatin - administration & dosage | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Antiemetics - adverse effects | Female | Nausea - drug therapy | Vomiting - prevention & control | Quinuclidines - adverse effects | Doxorubicin - administration & dosage | Dexamethasone - administration & dosage | Double-Blind Method | Morpholines - administration & dosage | Metoclopramide - administration & dosage | Vomiting - drug therapy | Neoplasms - drug therapy | Nausea - prevention & control | Vomiting - chemically induced | Metoclopramide - adverse effects | Cisplatin - adverse effects | Benzodiazepines - administration & dosage | Aged | Benzodiazepines - adverse effects | Isoquinolines - administration & dosage | Doxorubicin - adverse effects | Care and treatment | Cyclophosphamide | Anthracyclines | Dexamethasone | Nausea | Cancer | Side effects | Drug therapy | Vomiting | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 04/2018, Volume 36, Issue 10, pp. 1000 - 1006
Anthracyclines - adverse effects | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Palonosetron - adverse effects | Humans | Middle Aged | Antiemetics - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Dexamethasone - adverse effects | Male | Cyclophosphamide - adverse effects | Cisplatin - administration & dosage | Anthracyclines - administration & dosage | Placebos | Adult | Female | Dexamethasone - administration & dosage | Neurokinin-1 Receptor Antagonists - adverse effects | Double-Blind Method | Drug Administration Schedule | Neurokinin-1 Receptor Antagonists - administration & dosage | Palonosetron - administration & dosage | Cisplatin - adverse effects | Quality of Life | Aged
Journal Article
International journal of pharmaceutics, ISSN 0378-5173, 2007, Volume 337, Issue 1, pp. 1 - 24
Intranasal drug delivery | Pharmacokinetics | Nasal mucosa | Physicochemical properties | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Pharmaceutical technology. Pharmaceutical industry | Biological and medical sciences | Medical sciences | General pharmacology | Pharmacology. Drug treatments | Cholinesterase Inhibitors - pharmacokinetics | Hypnotics and Sedatives - chemistry | Central Nervous System - metabolism | Molecular Weight | Humans | Vaccines - pharmacokinetics | Cholinesterase Inhibitors - chemistry | Hypnotics and Sedatives - administration & dosage | Antiemetics - administration & dosage | Analgesics - pharmacokinetics | Antiemetics - pharmacokinetics | Inflammation - metabolism | Vaccines - chemistry | Cardiovascular Agents - pharmacokinetics | Drug Compounding | Antiemetics - chemistry | Nasal Mucosa - metabolism | Cardiovascular Agents - administration & dosage | Drug Administration Schedule | Hypnotics and Sedatives - pharmacokinetics | Drug Stability | Solubility | Analgesics - administration & dosage | Administration, Intranasal | Chemistry, Pharmaceutical | Carrier Proteins - metabolism | Cholinesterase Inhibitors - administration & dosage | Analgesics - chemistry | Hydrophobic and Hydrophilic Interactions | Vaccines - administration & dosage | Cardiovascular Agents - chemistry | Index Medicus
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 09/2012, Volume 308, Issue 12, pp. 1221 - 1226
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Head and neck surgery. Maxillofacial surgery. Dental surgery. Orthodontics | Biological and medical sciences | General aspects | Medical sciences | Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases | Surgery of the upper aerodigestive tract | Perioperative Care | Severity of Illness Index | Prospective Studies | Double-Blind Method | Humans | Child, Preschool | Dexamethasone - adverse effects | Male | Postoperative Hemorrhage - chemically induced | Risk | Postoperative Nausea and Vomiting - prevention & control | Dexamethasone - therapeutic use | Tonsillectomy | Antiemetics - therapeutic use | Adolescent | Antiemetics - adverse effects | Female | Child | Complications and side effects | Dexamethasone | Complications | Surgery | Causes of | Hemorrhage | Risk factors | Clinical trials | Drug therapy | Throat surgery | Children & youth | Index Medicus | Abridged Index Medicus
Journal Article
European journal of clinical pharmacology, ISSN 0031-6970, 11/2012, Volume 68, Issue 11, pp. 1465 - 1472
Biomedicine | Buspirone | Pharmacology/Toxicology | Randomised clinical trial | Antiemetic | Postoperative nausea and vomiting | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Biological and medical sciences | Pharmacology. Drug treatments | Medical sciences | Anti-Anxiety Agents - administration & dosage | Injections, Intravenous | Buspirone - blood | Dopamine Antagonists - pharmacokinetics | Humans | Middle Aged | Receptors, Dopamine D3 - metabolism | Antiemetics - administration & dosage | Male | Buspirone - pharmacokinetics | Receptors, Dopamine D2 - metabolism | Dopamine Antagonists - administration & dosage | Incidence | Dose-Response Relationship, Drug | Young Adult | Anti-Anxiety Agents - pharmacokinetics | Buspirone - administration & dosage | Antiemetics - pharmacokinetics | Antiemetics - therapeutic use | Aged, 80 and over | Adult | Anti-Anxiety Agents - adverse effects | Antiemetics - adverse effects | Female | Anti-Anxiety Agents - therapeutic use | Buspirone - adverse effects | Receptors, Dopamine D3 - antagonists & inhibitors | Buspirone - therapeutic use | Receptor, Serotonin, 5-HT1A - metabolism | Postoperative Nausea and Vomiting - epidemiology | Double-Blind Method | Dopamine Antagonists - therapeutic use | Serotonin 5-HT1 Receptor Agonists - therapeutic use | Serotonin 5-HT1 Receptor Agonists - adverse effects | Postoperative Nausea and Vomiting - prevention & control | Receptor, Serotonin, 5-HT1A - chemistry | Buspirone - analogs & derivatives | Dopamine Antagonists - adverse effects | Serotonin 5-HT1 Receptor Agonists - administration & dosage | Aged | Dopamine D2 Receptor Antagonists | Postoperative Nausea and Vomiting - blood | Prevention | Complications and side effects | Buspirone hydrochloride | Adults | Nausea | Analysis | Postoperative period | Vomiting | Clinical trials | Pharmacology | Drug therapy | Clinical outcomes | Index Medicus
Journal Article
European spine journal, ISSN 0940-6719, 9/2013, Volume 22, Issue 9, pp. 2089 - 2096
Mobilization | Surgical Orthopedics | Medicine & Public Health | Opioid consumption | Multimodal pain treatment | Major spine surgery | Neurosurgery | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Orthopedics | Science & Technology | Acetaminophen - adverse effects | Postoperative Nausea and Vomiting - chemically induced | Pain, Postoperative - drug therapy | Humans | Middle Aged | Acetaminophen - administration & dosage | Antiemetics - administration & dosage | Dexamethasone - adverse effects | Male | gamma-Aminobutyric Acid - administration & dosage | Spinal Fusion - adverse effects | Case-Control Studies | Young Adult | Analgesics, Opioid - adverse effects | Analgesics, Non-Narcotic - adverse effects | Aged, 80 and over | Amines - administration & dosage | Adult | Antiemetics - adverse effects | Female | Amines - adverse effects | Drug Therapy, Combination | gamma-Aminobutyric Acid - adverse effects | Spinal Diseases - surgery | Dexamethasone - administration & dosage | Cyclohexanecarboxylic Acids - adverse effects | Cyclohexanecarboxylic Acids - administration & dosage | Analgesics, Non-Narcotic - administration & dosage | Postoperative Nausea and Vomiting - drug therapy | Analgesics, Opioid - administration & dosage | Adolescent | Aged | Care and treatment | Pain | Corticosteroids | Anesthesia | Morphine | Nausea | Chronic pain | Index Medicus | Original
Journal Article
Cancer chemotherapy and pharmacology, ISSN 0344-5704, 6/2019, Volume 83, Issue 6, pp. 1091 - 1097
Granisetron | Medicine & Public Health | Triplet antiemetic | Oncology | Cancer Research | High emetogenic chemotherapy | Breast cancer | Pharmacology/Toxicology | Palonosetron | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Dexamethasone - administration & dosage | Granisetron - administration & dosage | Prospective Studies | Nausea - chemically induced | Aprepitant - administration & dosage | Humans | Middle Aged | Antiemetics - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Palonosetron - administration & dosage | Epirubicin - administration & dosage | Breast Neoplasms - drug therapy | Nausea - prevention & control | Vomiting - chemically induced | Adult | Female | Aged | Drug Therapy, Combination | Vomiting - prevention & control | Doxorubicin - administration & dosage | Aprepitant | Women | Care and treatment | Anthracyclines | Corticosteroids | Oncology, Experimental | Nausea | Research | Cancer patients | Chemotherapy | Comparative analysis | Health aspects | Cancer | Antiemetics and antinauseants | Intravenous administration | Dexamethasone | Prophylaxis | Cancer therapies | Patients | Doxorubicin | Cyclophosphamide | Vomiting | Epirubicin | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 11/2011, Volume 29, Issue 31, pp. 4189 - 4198
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Tumors | Serotonin Antagonists - administration & dosage | Dexamethasone - administration & dosage | Drug Administration Schedule | Nausea - chemically induced | Humans | Morpholines - administration & dosage | Radiotherapy - adverse effects | Vomiting - drug therapy | Quinuclidines - administration & dosage | Vomiting - chemically induced | Nausea - etiology | Antineoplastic Agents - adverse effects | Antiemetics - therapeutic use | Vomiting - etiology | Surveys and Questionnaires | Infusions, Intravenous | Nausea - drug therapy | Isoquinolines - administration & dosage | Vomiting - prevention & control | Neurokinin-1 Receptor Antagonists | Index Medicus | ASCO Special | Gdln1 | Cmpl4 | Cmpl3
Journal Article